Innovative Study Design

Learn more

Clinical Trials Execution

Learn more

Data Analysis Center

Learn more

Event Adjudication

Learn more

HCRI designs and runs clinical trials with world-class academic researchers and industry sponsors. We combine the logistical capabilities of a contract research organization with world-class academic scientific leadership.

We have a proven track record in cardiology, central nervous system, and pulmonology, and our research and publications show it.

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

A new study from HCRI highlights the importance of post market surveillance stent studies to depict safety signals. Postmarket surveillance of zotarolimus-eluting stents shows similar efficacy compared with premarket studies despite differences in patient populations but finds higher risk of myocardial infarction (MI), according to a paper published online June 9, 2014, in the American Journal of Cardiology.

Boehringer Ingelheim Planning to Initiate Two New Global Clinical Trials of Pradaxa® (dabigatran etexilate mesylate).

New clinical trials of PRADAXA in different patient populations to add data to RE-VOLUTION®, BI’s extensive clinical trial program.

AHA: Renal Stenting No Better Than Meds

American Heart Association Meeting Coverage: Renal artery stenting was no more helpful than optimal medical therapy alone for moderately severe renal artery stenosis, the CORAL trial showed.